{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:14Z","timestamp":1793459654496,"version":"4.5.0"},"reference-count":33,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2022,3,30]]},"DOI":"10.1536\/ihj.21-390","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T22:07:31Z","timestamp":1645135651000},"page":"255-263","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Implication of the Right Ventricular\/Left Ventricular Diameter Ratio in Patients with Pulmonary Thromboembolism"],"prefix":"10.1536","volume":"63","author":[{"given":"Masatsugu","family":"Miyagawa","sequence":"first","affiliation":[{"name":"Division of Cardiology, Nihon University Itabashi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nihon University Itabashi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Fukamachi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nihon University Itabashi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Suita Tokushukai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Nakamura Medical Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Kuwana City Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morimasa","family":"Takayama","sequence":"additional","affiliation":[{"name":"Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular, Respiratory and General Surgery, Nihon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mo","sequence":"additional","affiliation":[{"name":"Yokohama Minami Kyosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Osaka Police Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakamura M, Yamada N, Ito M. Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy. J Cardiol 2015; 66: 451-9.","DOI":"10.1016\/j.jjcc.2015.03.012"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379: 1835-46.","DOI":"10.1016\/S0140-6736(11)61904-1"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Fr\u00e9mont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right\/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 2008; 133: 358-62.","DOI":"10.1378\/chest.07-1231"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Konstantinides SV, Meyer G, Becattini C, <i>et al<\/i>. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54.","DOI":"10.1183\/13993003.01647-2019"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Klok FA, Dzikowska-Diduch O, Kostrubiec M, <i>et al<\/i>. Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost 2016; 14: 121-8.","DOI":"10.1111\/jth.13175"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Trujillo-Santos J, den Exter PL, G\u00f3mez V, <i>et al<\/i>. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost 2013; 11: 1823-32.","DOI":"10.1111\/jth.12393"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004; 110: 3276-80.","DOI":"10.1161\/01.CIR.0000147612.59751.4C"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Etesamifard N, Shirani S, Jenab Y, Lotfi-Tokaldany M, Pourjafari M, Jalali A. Role of clinical and pulmonary computed tomography angiographic parameters in the prediction of short- and long-term mortality in patients with pulmonary embolism. Intern Emerg Med 2016; 11: 405-13.","DOI":"10.1007\/s11739-015-1376-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mavrakanas T, Bounameaux H. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther 2011; 130: 46-58.","DOI":"10.1016\/j.pharmthera.2010.12.007"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Kearon C, Akl EA, Ornelas J, <i>et al<\/i>. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315-52.","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Weitz JI, Lensing AWA, Prins MH, <i>et al<\/i>. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med 2017; 376: 1211-22.","DOI":"10.1056\/NEJMoa1700518"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bauersachs R, Berkowitz SD, Brenner B, <i>et al<\/i>. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-510.","DOI":"10.1056\/NEJMoa1007903"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. B\u00fcller HR, Prins MH, Lensin AW, <i>et al<\/i>. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287-97.","DOI":"10.1056\/NEJMoa1113572"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Prins MH, Lensing AW, Bauersachs R, <i>et al<\/i>. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J 2013; 11: 21.","DOI":"10.1186\/1477-9560-11-21"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okumura Y, Fukuda I, Nakamura M, <i>et al<\/i>. A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J&apos;xactly Study). Circ J 2020; 84: 1912-21.","DOI":"10.1253\/circj.CJ-20-0636"},{"key":"16","doi-asserted-by":"crossref","first-page":"e020286","DOI":"10.1136\/bmjopen-2017-020286","volume":"8","year":"2018","unstructured":"16. Okumura Y, Fukuda I, Nakamura M, <i>et al<\/i>. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness &amp; Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J&apos;xactly) study. BMJ Open 2018; 8: e020286.","journal-title":"BMJ Open","ISSN":"https:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jim\u00e9nez D, Aujesky D, Moores L, <i>et al<\/i>. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-9.","DOI":"10.1001\/archinternmed.2010.199"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lu MT, Demehri S, Cai T, <i>et al<\/i>. Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism. AJR Am J Roentgenol 2012; 198: 1353-60.","DOI":"10.2214\/AJR.11.7439"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Collomb D, Paramelle PJ, Calaque O, <i>et al<\/i>. Severity assessment of acute pulmonary embolism: evaluation using helical CT. Eur Radiol 2003; 13: 1508-14.","DOI":"10.1007\/s00330-002-1804-5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. van der, Meer RW, Pattynama PM, van Strijen MJ, <i>et al<\/i>. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology 2005; 235: 798-803.","DOI":"10.1148\/radiol.2353040593"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cho SU, Cho YD, Choi SH, <i>et al<\/i>. Assessing the severity of pulmonary embolism among patients in the emergency department: Utility of RV\/LV diameter ratio. PLoS One 2020; 15: e0242340.","DOI":"10.1371\/journal.pone.0242340"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-4.","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamashita Y, Murata K, Morimoto T, <i>et al<\/i>. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry. Thromb Res 2019; 184: 50-7.","DOI":"10.1016\/j.thromres.2019.10.029"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Jim\u00e9nez D, Lobo JL, Monreal M, <i>et al<\/i>. Prognostic significance of multidetector CT in normotensive patients with pulmonary embolism: results of the protect study. Thorax 2014; 69: 109-15.","DOI":"10.1136\/thoraxjnl-2012-202900"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Morris MF, Gardner BA, Gotway MB, Thomsen KM, Harmsen WS, Araoz PA. CT findings and long-term mortality after pulmonary embolism. AJR Am J Roentgenol 2012; 198: 1346-52.","DOI":"10.2214\/AJR.11.6801"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Araoz PA, Gotway MB, Harrington JR, Harmsen WS, Mandrekar JN. Pulmonary embolism: prognostic CT findings. Radiology 2007; 242: 889-97.","DOI":"10.1148\/radiol.2423051441"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Caranobe C, Petitou M, Dupouy D, <i>et al<\/i>. Heparin fractions with high and low affinities to antithrombin III are cleared at different rates. Thromb Res 1986; 43: 635-41.","DOI":"10.1016\/0049-3848(86)90100-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol 1990; 3: 531-44.","DOI":"10.1016\/S0950-3536(05)80017-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Manson L, Weitz JI, Podor TJ, Hirsh J, Young E. The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance. J Lab Clin Med 1997; 130: 649-55.","DOI":"10.1016\/S0022-2143(97)90115-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eerenberg ES, Middeldorp S, Levi M, Lensing AW, B\u00fcller HR. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemost 2015; 13: 1590-6 (doi: 10.1111\/jth.13051).","DOI":"10.1111\/jth.13051"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yamada N, Hirayama A, Maeda H, <i>et al<\/i>. Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program. Thromb J 2015; 13: 2.","DOI":"10.1186\/s12959-015-0035-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. C\u00f4t\u00e9 B, Jim\u00e9nez D, Planquette B, <i>et al<\/i>. Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism. Eur Respir J 2017; 50.","DOI":"10.1183\/1393003.congress-2017.PA561"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ammari Z, Hasnie AA, Ruzieh M, <i>et al<\/i>. Prognostic Value of Computed Tomography Versus Echocardiography Derived Right to Left Ventricular Diameter Ratio in Acute Pulmonary Embolism. Am J Med Sci 2021; 361: 445-50.","DOI":"10.1016\/j.amjms.2020.07.008"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-390\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:56:33Z","timestamp":1700243793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-390\/_article"}},"subtitle":["Subanalysis from the J'xactly Study"],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-390","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"21-390"}}